Pieris Pharmaceuticals Company Profile (NASDAQ:PIRS)

About Pieris Pharmaceuticals

Pieris Pharmaceuticals logoPieris Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company's pipeline includes immuno-oncology multi-specifics tailored for the tumor micro-environment, an inhaled Anticalin to treat uncontrolled asthma and a half-life-optimized Anticalin to treat anemia. Its Anticalins proteins are a class of low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular weight human proteins typically found in blood plasma and other bodily fluids. It is focused on developing three drug candidates, which include PRS-080, PRS-060 and PRS-300 series. Its PRS-080 is an Anticalin drug candidate targeting hepcidin. The Company's second Anticalin drug candidate, PRS-060, binds to the IL-4 receptor alpha-chain (IL-4RA), thereby inhibiting the actions of IL-4 and IL-13, two cytokines known to be mediators in the inflammatory cascade that causes asthma and other inflammatory diseases. PRS-343 is an Anticalin-based drug candidate.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: PIRS
  • CUSIP:
Key Metrics:
  • Previous Close: $1.61
  • 50 Day Moving Average: $1.69
  • 200 Day Moving Average: $1.81
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.73
  • P/E Growth: 0.00
  • Market Cap: $69.32M
  • Outstanding Shares: 43,058,000
  • Beta: 1.64
Additional Links:
Companies Related to Pieris Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Pieris Pharmaceuticals (NASDAQ:PIRS) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $8.33 (417.60% upside)

Analysts' Ratings History for Pieris Pharmaceuticals (NASDAQ:PIRS)
Show:
DateFirmActionRatingPrice TargetDetails
8/5/2016Roth CapitalReiterated RatingBuy$6.00View Rating Details
3/9/2016JMP SecuritiesLower Price TargetMarket Outperform$10.00 -> $9.00View Rating Details
12/8/2015Oppenheimer Holdings Inc.Reiterated RatingBuy$8.00 -> $10.00View Rating Details
(Data available from 8/26/2014 forward)

Earnings

Earnings History for Pieris Pharmaceuticals (NASDAQ:PIRS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/9/2016        
8/10/2016Q216($0.15)($0.14)$1.07 millionViewN/AView Earnings Details
5/12/2016Q116($0.12)($0.10)ViewN/AView Earnings Details
3/23/2016Q415($0.12)($0.07)$3.27 million$2.14 millionViewN/AView Earnings Details
11/12/2015Q315($0.11)($0.10)ViewN/AView Earnings Details
8/13/2015Q215($0.14)($0.12)$160.24 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Pieris Pharmaceuticals (NASDAQ:PIRS)
Current Year EPS Consensus Estimate: $-0.55 EPS
Next Year EPS Consensus Estimate: $-0.59 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.03$0.03$0.03
Q2 20162($0.16)($0.12)($0.14)
Q3 20162($0.14)($0.12)($0.13)
Q4 20162($0.14)($0.12)($0.13)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Pieris Pharmaceuticals (NASDAQ:PIRS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Pieris Pharmaceuticals (NASDAQ:PIRS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/14/2016Louis MatisSVPBuy10,000$1.70$17,000.00View SEC Filing  
6/13/2016Darlene M Deptula-HicksCFOBuy5,000$1.66$8,300.00View SEC Filing  
6/13/2016Stephen S YoderCEOBuy6,000$1.68$10,080.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Pieris Pharmaceuticals (NASDAQ:PIRS)
DateHeadline
News IconHow is the Crowd Rating Shares of Pieris Pharmaceuticals Inc (NASDAQ:PIRS)? - Post News (NASDAQ:PIRS)
www.kentuckypostnews.com - August 24 at 6:36 PM
News IconStock Tracking Lower for the Quarter: Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) - Post News (NASDAQ:PIRS)
www.kentuckypostnews.com - August 21 at 10:50 AM
finance.yahoo.com logoPIERIS PHARMACEUTICALS, INC. Financials (NASDAQ:PIRS)
finance.yahoo.com - August 19 at 6:45 PM
capitalcube.com logoPieris Pharmaceuticals, Inc. :PIRS-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NASDAQ:PIRS)
www.capitalcube.com - August 12 at 6:58 PM
finance.yahoo.com logoPIRS: Development of Multiple Anticalin® Products Continues… (NASDAQ:PIRS)
finance.yahoo.com - August 12 at 6:58 PM
biz.yahoo.com logoPIERIS PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements (NASDAQ:PIRS)
biz.yahoo.com - August 11 at 10:05 AM
sg.finance.yahoo.com logoPieris Pharmaceuticals reports 2Q loss (NASDAQ:PIRS)
sg.finance.yahoo.com - August 10 at 7:18 PM
kcregister.com logoPieris Pharmaceuticals, Inc. (NASDAQ:PIRS) rose 1.39%, The Spectranetics Corporation (NASDAQ:SPNC), General ... - KC Register (NASDAQ:PIRS)
www.kcregister.com - August 1 at 11:32 AM
finance.yahoo.com logoPieris Pharmaceuticals to Host Second Quarter 2016 Investor Call and Corporate Update on August 11, 2016 (NASDAQ:PIRS)
finance.yahoo.com - August 1 at 8:00 AM
marketwired.com logoPieris Pharmaceuticals Appoints Julian Adams, Ph.D., to Its Board of Directors - Marketwired (press release) (NASDAQ:PIRS)
www.marketwired.com - July 27 at 7:13 PM
biz.yahoo.com logoPIERIS PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and (NASDAQ:PIRS)
biz.yahoo.com - July 26 at 9:23 AM
News IconChecking in on Stock Volatility for: Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) - Engelwood Daily (NASDAQ:PIRS)
www.engelwooddaily.com - July 22 at 6:42 PM
News IconPieris Pharmaceuticals Inc (NASDAQ:PIRS): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:PIRS)
www.engelwooddaily.com - July 22 at 6:42 PM
News IconPieris Pharmaceuticals Incorporated (NASDAQ:PIRS) Shorted Shares Increased 43.71% After Market Selling - Consumer Eagle (NASDAQ:PIRS)
www.consumereagle.com - July 22 at 6:42 PM
news.cmlviz.com logoPieris Pharmaceuticals Inc Stock Technicals at Critical Inflection Point - CML News (NASDAQ:PIRS)
news.cmlviz.com - July 21 at 9:43 AM
News IconEquity Roundup: Stock Performance Focus on Pieris Pharmaceuticals Inc (NASDAQ:PIRS) - Press Telegraph (NASDAQ:PIRS)
presstelegraph.com - July 21 at 9:43 AM
News IconStock Focus: Following Analyst Expectations on Shares of Pieris Pharmaceuticals Inc (NASDAQ:PIRS) - TGP (NASDAQ:PIRS)
telanaganapress.com - July 20 at 9:41 AM
News IconEarnings Focus and Crowd Sourced Sentiment Review for Pieris Pharmaceuticals Inc (NASDAQ:PIRS) - TGP (NASDAQ:PIRS)
telanaganapress.com - July 20 at 9:41 AM
News IconPieris Pharmaceuticals Incorporated (NASDAQ:PIRS) Sellers Covered 15.84% of Their Shorts - Consumer Eagle (NASDAQ:PIRS)
www.consumereagle.com - July 19 at 6:38 AM
kcregister.com logoWoodward, Inc. (NASDAQ:WWD) Fell -0.32%: Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), Nippon Telegraph and ... - KC Register (NASDAQ:PIRS)
www.kcregister.com - July 15 at 5:53 PM
News IconTrading Performance and Target Watch for Pieris Pharmaceuticals Inc (NASDAQ:PIRS) - Press Telegraph (NASDAQ:PIRS)
presstelegraph.com - July 15 at 11:58 AM
News IconAnalyst Target and Average Rating Watch: Pieris Pharmaceuticals Inc (NASDAQ:PIRS) - Press Telegraph (NASDAQ:PIRS)
presstelegraph.com - July 15 at 11:58 AM
News IconPieris Pharmaceuticals Inc (NASDAQ:PIRS) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:PIRS)
www.engelwooddaily.com - July 15 at 11:58 AM
news.cmlviz.com logoPieris Pharmaceuticals Inc Stock Momentum at Critical Inflection Point - CML News (NASDAQ:PIRS)
news.cmlviz.com - July 11 at 6:50 PM
News IconStock Rating Watch and Earnings Insight for Pieris Pharmaceuticals Inc (NASDAQ:PIRS) - Press Telegraph (NASDAQ:PIRS)
presstelegraph.com - July 11 at 6:50 PM
News IconIncreased Volatility on Shares of: Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) - Engelwood Daily (NASDAQ:PIRS)
www.engelwooddaily.com - July 8 at 6:51 PM
News IconCan Pieris Pharmaceuticals Inc (NASDAQ:PIRS) Improve on the Earnings Front? - Engelwood Daily (NASDAQ:PIRS)
www.engelwooddaily.com - July 8 at 6:51 PM
News IconCompany Stock Focus for Pieris Pharmaceuticals Inc (NASDAQ:PIRS): Which Way Will Shares Head? - Press Telegraph (NASDAQ:PIRS)
presstelegraph.com - July 8 at 6:51 PM
fiscalstandard.com logoBroker Outlook For Pieris Pharmaceuticals, Inc. (PIRS) - Fiscal Standard (NASDAQ:PIRS)
www.fiscalstandard.com - July 8 at 6:51 PM
ftsenews.co.uk logoNew Broker Ratings For Pieris Pharmaceuticals, Inc. (PIRS) - FTSE News (NASDAQ:PIRS)
www.ftsenews.co.uk - July 6 at 11:29 AM
News IconPieris Pharmaceuticals Inc (NASDAQ:PIRS) Stock Update: Check on Ratings and Target Price - Telanagana Press (NASDAQ:PIRS)
telanaganapress.com - July 5 at 6:36 PM
News IconPieris Pharmaceuticals Incorporated (NASDAQ:PIRS) Shorted Shares Decreased By 15.84% - Engelwood Daily (NASDAQ:PIRS)
www.engelwooddaily.com - July 2 at 9:36 AM
News IconWatching Stock Volatility for: Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) - Engelwood Daily (NASDAQ:PIRS)
www.engelwooddaily.com - July 1 at 9:36 AM
News IconUpdate on Stock Volatility for: Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) - Engelwood Daily (NASDAQ:PIRS)
www.engelwooddaily.com - July 1 at 9:36 AM
News IconHow Analysts Rated Pieris Pharmaceuticals Inc (NASDAQ:PIRS) Last Week? - Engelwood Daily (NASDAQ:PIRS)
www.engelwooddaily.com - July 1 at 9:36 AM
biz.yahoo.com logoPIERIS PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to (NASDAQ:PIRS)
biz.yahoo.com - July 1 at 8:49 AM
News IconPieris Pharmaceuticals Inc (NASDAQ:PIRS) Company Rating and Target Watch - Telanagana Press (NASDAQ:PIRS)
telanaganapress.com - June 29 at 9:38 AM
News IconShare Update and Earnings Review for Pieris Pharmaceuticals Inc (NASDAQ:PIRS) - Press Telegraph (NASDAQ:PIRS)
presstelegraph.com - June 27 at 10:59 AM
News IconHow Many Pieris Pharmaceuticals Inc (NASDAQ:PIRS)'s Analysts Are Bullish? - Press Telegraph (NASDAQ:PIRS)
presstelegraph.com - June 24 at 6:54 PM
News IconPieris Pharmaceuticals Incorporated (NASDAQ:PIRS) Short Interest Increased By 18.12% - Press Telegraph (NASDAQ:PIRS)
presstelegraph.com - June 24 at 9:27 AM
News IconCovering the Bases on Pieris Pharmaceuticals Inc (NASDAQ:PIRS): Where is the Stock Going? - Press Telegraph (NASDAQ:PIRS)
presstelegraph.com - June 24 at 9:27 AM
fiscalstandard.com logoPieris Pharmaceuticals, Inc. (PIRS) Current Analyst Ratings - Fiscal Standard (NASDAQ:PIRS)
www.fiscalstandard.com - June 24 at 9:27 AM
News IconPieris Pharmaceuticals Inc (NASDAQ:PIRS) Earnings Glance and Target Price Review - Engelwood Daily (NASDAQ:PIRS)
www.engelwooddaily.com - June 24 at 9:27 AM
News IconEquity Research and Technical Review on Pieris Pharmaceuticals Inc (NASDAQ:PIRS) - Press Telegraph (NASDAQ:PIRS)
presstelegraph.com - June 23 at 9:30 AM
kcregister.com logoVeriFone Systems, Inc. (NYSE:PAY) Declined -1.38%: Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), American Water ... - KC Register (NASDAQ:PIRS)
www.kcregister.com - June 22 at 6:48 PM
finance.yahoo.com logoPieris Pharmaceuticals Announces Participation at Two Upcoming Investor Conferences (NASDAQ:PIRS)
finance.yahoo.com - June 14 at 7:59 AM
biz.yahoo.com logoPIERIS PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events (NASDAQ:PIRS)
biz.yahoo.com - June 9 at 5:23 PM
marketwatch.com logoPieris Pharmaceuticals Announces Closing of $16.5 Million Private Placement (NASDAQ:PIRS)
www.marketwatch.com - June 8 at 7:15 PM
biz.yahoo.com logoPIERIS PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:PIRS)
biz.yahoo.com - June 8 at 5:02 PM
News IconPieris Pharmaceuticals Incorporated (NASDAQ:PIRS) Short Interest Decreased By 12.32% - HNN (NASDAQ:PIRS)
hintsnewsnetwork.com - June 4 at 9:45 AM

Social

Pieris Pharmaceuticals (NASDAQ:PIRS) Chart for Friday, August, 26, 2016


Last Updated on 8/26/2016 by MarketBeat.com Staff